EBOS Group Limited (ASX:EBO) Insider Mark Bloom Buys 2,000 Shares

EBOS Group Limited (ASX:EBO) insider Mark Bloom bought 2,000 shares of EBOS Group stock in a transaction on Friday, May 30th. The shares were purchased at an average price of A$34.40 ($22.34) per share, for a total transaction of A$68,800.00 ($44,675.32).

EBOS Group Price Performance

The company has a market cap of $8.20 billion, a P/E ratio of 27.51 and a beta of 0.26. The company has a debt-to-equity ratio of 66.89, a current ratio of 0.95 and a quick ratio of 0.76.

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.